Skip to content

Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation

Evaluation of Piezosurgical Buccal Plate Repositioning Technique for Horizontal Alveolar Ridge Augmentation Comparing Between Two Different Grafting Materials (a Randomized Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05317039
Enrollment
18
Registered
2022-04-07
Start date
2021-08-15
Completion date
2022-06-30
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss

Brief summary

Achieving prosthetically driven implant placement is a highly predictable treatment modality with reliable long-term results. Different surgical procedures have been used as a solution for reconstructing of the alveolar ridge with deficient volume. In the present study we demonstrate a modified alveolar ridge split technique for horizontal alveolar ridge augmentation (buccal plate repositioning technique) using the piezotome surgery. Evaluation of the effect of silica-calcium phosphate nanocomposite (SCPC) graft material versus demineralized freeze dried bone allograft (DFBA) in horizontal alveolar ridge augmentation before implant insertion will be performed.

Interventions

OTHERsilica-calcium phosphate nanocomposite SCPC

Patients will be treated with the buccal plate repositioning technique and grafted with SCPC then the grafted defect will be covered with a platelet-rich fibrin membrane.

OTHERfreezed dried bone

Patients will be treated with the buccal plate repositioning technique and grafted using DFDBA. then the grafted defect will be covered with a platelet-rich fibrin membrane.

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients with horizontal atrophy of the posterior mandible with pristine residual alveolar crest width from 2 to 4 mm. * Augmented area length in the mesial-distal direction of less than 20 mm. * Adequate physically healthy condition.

Exclusion criteria

* A systemic disease that would contraindicate oral surgical treatment. * Treated patients who had undergone therapy involving radiation * Patients who had received bone resection as part of an oncological treatment after a bone augmentation procedure. * Patients are subjected to intravenous and/or oral bisphosphonate therapy after the bone augmentation procedure.

Design outcomes

Primary

MeasureTime frameDescription
change in alveolar ridge widthat baseline and 6 monthsAll patients will receive a CBCT scan; immediately after surgery and at 6 months post-operatively. The images will be analyzed using OnDemand3D software (Cybermed Inc) CBCT analyzing software and compared to the pre-operative scan for alveolar ridge width evaluation.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026